中子捕获疗法的临床试验取得进展
Xiaoling Li1,2, Zhijie Liu1,2, Kejun Liu1,2
1Cancer Center, Dongguan Engineering Research Center for Innovative Boron Drugs and Novel Radioimmune Drugs, The Tenth Affiliated Hospital, Southern Medical University (Dongguan People's Hospital), Southern Medical University, Dongguan 523059, China.
Research (Washington, D.C.)
|January 12, 2026
概括
中子捕获疗法 (BNCT) 通过向瘤细胞提供精确的癌症治疗. 临床试验表明,BNCT改善了各种癌症的生存率和生活质量,应用范围不断扩大.
科学领域:
- 在瘤学瘤学.
- 辐射疗法 辐射疗法
- 核医学是一种核医学.
背景情况:
- 中子捕获疗法 (BNCT) 是一种使用核反应的射疗法.
- 它可以在生理生物层面上实现双重向,这对于根除恶性细胞而保护健康组织至关重要.
研究的目的:
- 为提供当前中子捕获疗法 (BNCT) 临床试验的全面概述.
- 总结各种瘤类型的治疗原则,当前状态和结果.
主要方法:
- 对BNCT现有的临床试验和科学文献的审查.
- 对不同类型癌症的治疗原则和结果的分析.
主要成果:
- BNCT对质母细胞瘤,头癌和肝癌有效,有可能改善整体存活率 (OS).
- 临床试验正在扩大,包括肺癌,乳腺癌和胃肠癌等.
结论:
- 中子源和载体的进步正在提高BNCT的有效性并扩大其应用.
- 预计BNCT与其他疗法的整合将改善局部瘤控制,操作系统和患者的生活质量.
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K